IAAG
GILD icon

Innovative Asset Advisors Group’s Gilead Sciences GILD Stock Holding History

Innovative Asset Advisors Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-574
Closed -$80K – 579
2026
Q1 		$80K Buy
+574
New +$80.4K 0.05% 243

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Innovative Asset Advisors Group's GILD Position: Q2 2026 in Review

Innovative Asset Advisors Group sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 574 shares — an estimated $80K sold.

Innovative Asset Advisors Group first reported a position in GILD in Q1 2026 and held it in 1 quarter. The position peaked at $80K in Q1 2026. 2,169 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Innovative Asset Advisors Group reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Innovative Asset Advisors Group sold 574 Gilead Sciences shares in Q2 2026, an estimated $80K.
  • Innovative Asset Advisors Group first reported a position in Gilead Sciences in Q1 2026 and held it in 1 quarter.
  • Innovative Asset Advisors Group's Gilead Sciences position peaked at $80K in Q1 2026.
  • 2,169 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Innovative Asset Advisors Group's 13F filing for Q2 2026, filed 5 Aug 2026.